发布求助
文献互助 智能选刊 最新文献

Herzschrittmachertherapie und Elektrophysiologie最新文献

筛选
英文 中文
[SVT in the EP lab: electrograms don't always show the reentry circuit]. [EP 实验室中的 SVT：电图并不总是显示再入电路]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-08-30 DOI: 10.1007/s00399-024-01039-5
Harilaos Bogossian, Sebastian Robl, Nana-Yaw Bimpong-Buta, Konstantinos Iliodromitis
{"title":"[SVT in the EP lab: electrograms don't always show the reentry circuit].","authors":"Harilaos Bogossian, Sebastian Robl, Nana-Yaw Bimpong-Buta, Konstantinos Iliodromitis","doi":"10.1007/s00399-024-01039-5","DOIUrl":"10.1007/s00399-024-01039-5","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"334-337"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in the terminology of second-degree atrioventricular block. 二度房室传导阻滞术语的挑战。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-18 DOI: 10.1007/s00399-024-01055-5
S Serge Barold, Carsten W Israel, Bengt Herweg
{"title":"Challenges in the terminology of second-degree atrioventricular block.","authors":"S Serge Barold, Carsten W Israel, Bengt Herweg","doi":"10.1007/s00399-024-01055-5","DOIUrl":"10.1007/s00399-024-01055-5","url":null,"abstract":"<p><p>The terminology of second-degree atrioventricular block has evolved over time, thereby creating some confusion and misinterpretations. Strict adherence to standard terminology and the appropriate use of eponyms are important to avoid diagnostic errors.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"324-326"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulsed-field ablation-is it the only energy source for ablation in the future? : Pro/Contra]. [脉冲场消融--它是未来消融的唯一能源吗？ : Pro/Contra]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-03 DOI: 10.1007/s00399-024-01035-9
Melanie Gunawardene, Thomas Arentz
{"title":"[Pulsed-field ablation-is it the only energy source for ablation in the future? : Pro/Contra].","authors":"Melanie Gunawardene, Thomas Arentz","doi":"10.1007/s00399-024-01035-9","DOIUrl":"10.1007/s00399-024-01035-9","url":null,"abstract":"<p><p>Pulsed field ablation (PFA) is a nonthermal energy source used for cardiac ablation procedures. Cell death during PFA occurs via electroporation: ultrarapid (micro- to nanosecond) electrical pulses are applied to destabilize cell membranes causing irreversible pores. PFA leads to preferential ablation of myocardiocytes, sparing adjacent tissue like the esophagus or phrenic nerve. Preliminary clinical studies show high efficacy and a good safety profile in atrial fibrillation patients undergoing pulmonary vein isolation. The question remains, however, whether this new technology will replace well-known and established thermal energy sources like radiofrequency current or cryoablation within the next 5 years.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"263-267"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Initial ablation of atrial fibrillation-Is pulmonary vein isolation sufficient? : Pro and contra]. [心房颤动的初始消融--肺静脉隔离是否足够？ 赞成与反对]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.1007/s00399-024-01044-8
Kyoung-Ryul Julian Chun, Sascha Rolf
{"title":"[Initial ablation of atrial fibrillation-Is pulmonary vein isolation sufficient? : Pro and contra].","authors":"Kyoung-Ryul Julian Chun, Sascha Rolf","doi":"10.1007/s00399-024-01044-8","DOIUrl":"10.1007/s00399-024-01044-8","url":null,"abstract":"<p><p>Pulmonary vein isolation (PVI) is currently the gold standard for the ablation of atrial fibrillation (AF). Although this procedure shows good success rates, the recurrence rates after PVI alone are significantly higher in advanced AF and in the presence of comorbidities. Therefore, it is important to consider additional arrhythmogenic mechanisms outside the pulmonary veins, depending on the individual case, in order to improve the patients' outcome.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"268-273"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Controversies in rhythmology]. [节律学的争议]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-10-14 DOI: 10.1007/s00399-024-01048-4
Victoria Johnson, Philipp Sommer
{"title":"[Controversies in rhythmology].","authors":"Victoria Johnson, Philipp Sommer","doi":"10.1007/s00399-024-01048-4","DOIUrl":"10.1007/s00399-024-01048-4","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"255"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[(LV)EF is a poor predictor of sudden cardiac death : Pro/Contra]. (LV)EF是心脏性猝死的不良预测指标：Pro/Contra].
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-10 DOI: 10.1007/s00399-024-01041-x
Christian Butter, Gerd Hindricks
{"title":"[(LV)EF is a poor predictor of sudden cardiac death : Pro/Contra].","authors":"Christian Butter, Gerd Hindricks","doi":"10.1007/s00399-024-01041-x","DOIUrl":"10.1007/s00399-024-01041-x","url":null,"abstract":"<p><p>For more than two decades the left ventricular ejection fraction (LVEF) has been utilized with practically uncritical absolutism for the risk stratification of patients with ischemic and, historically, also nonischemic cardiomyopathy, in order to identify patients who could be threatened by sudden cardiac death. Based on historical data and in the absence of other better predictive parameters, the LVEF continues to appear in the guidelines unchanged, with cut-off values that lie in the region of the measurement accuracy of LVEF as determined by echocardiography. The basic identification of high-risk patients who then really benefit from an implantable cardioverter defibrillator (ICD) must be re-evaluated under the aspect of a meaningfully altered interventional and pharmaceutical treatment of heart failure.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"282-285"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atrial fibrillation in combination with severe mitral regurgitation : Which should be treated first, the atrial fibrillation or the mitral valve?] [心房颤动合并严重二尖瓣返流：应该先治疗心房颤动还是二尖瓣？］
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.1007/s00399-024-01045-7
Nora Köpcke, Fabian Barbieri, Mario Kasner, Markus Reinthaler, Ulf Landmesser, Martin Huemer, Philipp Attanasio
{"title":"[Atrial fibrillation in combination with severe mitral regurgitation : Which should be treated first, the atrial fibrillation or the mitral valve?]","authors":"Nora Köpcke, Fabian Barbieri, Mario Kasner, Markus Reinthaler, Ulf Landmesser, Martin Huemer, Philipp Attanasio","doi":"10.1007/s00399-024-01045-7","DOIUrl":"10.1007/s00399-024-01045-7","url":null,"abstract":"<p><strong>Background: </strong>The primary therapeutic approach for severe secondary mitral regurgitation (MR) in combination with atrial fibrillation is often not clear.</p><p><strong>Objectives/methods: </strong>To create a therapeutic guideline for daily clinical practice based on a case report as well as basic literature.</p><p><strong>Results: </strong>If a functional component is suspected, restoration of sinus rhythm may lead to a significant improvement in MR. The extent of the improvement and the time required to achieve this improvement are often difficult to predict.</p><p><strong>Conclusions: </strong>The involvement of an electrophysiologist is recommended in order to assess the likelihood of successful long-term rhythm control aimed at improving MR. In unclear cases, cardioversion combined with short-term administration of antiarrhythmic medication may be useful to demonstrate potential improvement of MR in sinus rhythm.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"303-311"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future : Pros and cons]. [抗心律失常药物在未来治疗心房颤动中不再重要：利弊]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-13 DOI: 10.1007/s00399-024-01047-5
Andreas Metzner, Constanze Schmidt
{"title":"[Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future : Pros and cons].","authors":"Andreas Metzner, Constanze Schmidt","doi":"10.1007/s00399-024-01047-5","DOIUrl":"10.1007/s00399-024-01047-5","url":null,"abstract":"<p><p>An early rhythm stabilization is the primary focus of the current treatment of atrial fibrillation. Based on current studies catheter ablation of pulmonary vein isolation (PVI) is an established component in the treatment of atrial fibrillation. Therefore, in the management of affected patients this procedure should be offered at an early stage in addition to the holistic treatment approach with consistent treatment of cardiovascular risk factors and thromboembolism prophylaxis with anticoagulants. Substances with an antiarrhythmic effect can be included in a supportive role in the management of atrial fibrillation. Pharmacotherapy could also perspectively play an important role in the treatment of the underlying atrial cardiomyopathy of the phenotype of atrial fibrillation. An understanding of the atrial pathophysiology of individual patients with adapted selection of suitable treatment strategies of ablation up to pharmacotherapy is decisive for the successful antiarrhythmic outcome. The decision on the treatment strategy must always be individually made together with the affected patient. The advantages and disadvantages of both options must be explained in detail and pre-existing comorbidities and risk factors must be included. Additionally, the individual wishes of the patient must be taken into account.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"274-281"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Everyone over the age of 65 years should wear a smartwatch : Pro and contra]. [65 岁以上的人都应佩戴智能手表：赞成与反对]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-25 DOI: 10.1007/s00399-024-01058-2
V Johnson, L Eckardt
{"title":"[Everyone over the age of 65 years should wear a smartwatch : Pro and contra].","authors":"V Johnson, L Eckardt","doi":"10.1007/s00399-024-01058-2","DOIUrl":"10.1007/s00399-024-01058-2","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the increasing number of comorbidities, and the improved technical possibilities for detection. A major complication of AF is stroke, whereby at-risk patients can be protected by oral anticoagulation if AF is diagnosed. The extent to which continuous screening for AF in patients with an increased risk of thromboembolic events should be carried out using wearables remains an important point in the current debate.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"290-295"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[My patients can go home in the evening after pulmonary vein isolation : Pros and cons]. [肺静脉隔离术后，我的病人晚上就能回家：利弊]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-11 DOI: 10.1007/s00399-024-01050-w
Burghard Schumacher, Suzanne de Waha, Roland R Tilz
{"title":"[My patients can go home in the evening after pulmonary vein isolation : Pros and cons].","authors":"Burghard Schumacher, Suzanne de Waha, Roland R Tilz","doi":"10.1007/s00399-024-01050-w","DOIUrl":"10.1007/s00399-024-01050-w","url":null,"abstract":"<p><p>Given the background of optimizing financial and personnel resources while aligning with patient needs, the concept of same-day discharge following pulmonary vein isolation (PVI) appears attractive. However, a non-selective approach to different strategies is inappropriate, as is often the case in medicine. A \"one size fits all\" approach is therefore not advisable for outpatient PVI. Instead, the primary focus should be on identifying which patients can safely and effectively undergo PVI in an outpatient setting and which patients would benefit from inpatient care. Both procedural and patient-specific criteria should be considered in this context. In addition, structural prerequisites must also be met. Ultimately, the decision as to whether outpatient PVI is feasible should remain with the treating physician and the patient.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"296-302"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信